Figure 2.
Maternal and fetal plasma asprosin levels upon overweight/obesity and GDM. (A and B) Maternal (A) and fetal (B) plasma asprosin levels stratified by BMI and GDM. (C and D) Maternal (C) and fetal (D) plasma asprosin levels stratified by GDM treatment (diet vs insulin). Statistics were performed with GraphPad Prism using two-way ANOVA and Mann–Whitney U-test (*P < 0.05). GDM, gestational diabetes mellitus.
This work is licensed under a 